NCT06104449 2026-03-06
MK-5684-005
Merck Sharp & Dohme LLC
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT06136598 2026-02-17
MK-5684-001
Merck Sharp & Dohme LLC
Phase 1 Active not recruiting
NCT05479578 2025-01-08
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
University of California, Davis
Phase 1 Active not recruiting
NCT04147806 2024-06-11
PROSINT
Albert Einstein College of Medicine
Phase 2 Active not recruiting